Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Peer Reviewed
See detailLow dose of dopamine infusion : hemodynamic and natriuretic responses
D'Orio, Vincenzo ULiege; El-Allaf, D

in Clinical Pharmacology & Therapeutics (1984), 35

Detailed reference viewed: 7 (0 ULiège)
Peer Reviewed
See detailLow dose of FSH early in estrous cycle enhances superovulatory response in heifers
Touati, Kamal ULiege; Vanderzwalmen, Pierre ULiege; Ectors, Fabien ULiege et al

in Theriogenology (1989), 31(1), 269

Detailed reference viewed: 12 (0 ULiège)
Peer Reviewed
See detailLow doses of FSH in early estrous cycle stimulate follicular growth and maturation as confirmed by subsequent superovulatory response
Touati, Kamal ULiege; Bormans, M; Ectors, Fabien ULiege et al

in Proceedings of the Annual Meeting AETE (1989)

Detailed reference viewed: 15 (0 ULiège)
Peer Reviewed
See detailLow doses of FSH stimulate follicular growth and maturation in anestrous heifers.
Beckers, Jean-François ULiege; Ballman-Wouters, P; Viviers-Donnay, I et al

in Theriogenology (1989)

Detailed reference viewed: 13 (0 ULiège)
Full Text
Peer Reviewed
See detailLow Energy Antiproton Annihilation in Nuclei
Cugnon, Joseph ULiege; Cahay, M.; Vandermeulen, Jacques

in Nuclear Physics A (1983), 393

Detailed reference viewed: 13 (0 ULiège)
Full Text
Peer Reviewed
See detailLow Energy Pions and Density Evolution in Relativistic Nuclear Collisions
Cugnon, Joseph ULiege; Koonin, S. E.

in Workshop on Nuclear Dynamics, Lawrence Berkeley Laboratory LBL-10688, (University of California, 1980), pp. 119-123 (1980)

Detailed reference viewed: 17 (0 ULiège)
Full Text
See detailLow flow regionalisation in the Walloon Region
Grandry, Maud ULiege; Verstraete, Arnaud; Gailliez, Sébastien et al

Report (2012)

Detailed reference viewed: 68 (8 ULiège)
Full Text
Peer Reviewed
See detailLow frequency electromagnetic waves in periodic structures
Guenneau, S.; Nicolet, A.; Geuzaine, Christophe ULiege et al

in International Journal of Applied Electromagnetics and Mechanics (2004), 19

Detailed reference viewed: 30 (1 ULiège)
Full Text
Peer Reviewed
See detailLow frequency rythms in human DNA sequences: A key to the organization of gene location and orientation?
Nicolay, Samuel ULiege; Argoul, F.; Touchon, M. et al

in Physical Review Letters (2004), 93(10), 108101

We explore large-scale nucleotide compositional fluctuations of the human genome using multi- resolution techniques. Analysis of the GC content and of the AT and GC skews reveals the existence of rhythms ... [more ▼]

We explore large-scale nucleotide compositional fluctuations of the human genome using multi- resolution techniques. Analysis of the GC content and of the AT and GC skews reveals the existence of rhythms with two main periods of 110 20 kb and 400 50 kb that enlighten a remarkable cooperative gene organization. We show that the observed nonlinear oscillations are likely to display all the characteristic features of chaotic strange attractors which suggests a very attractive deterministic picture: gene orientation and location, in relation with the structure and dynamics of chromatin, might be governed by a low-dimensional nonlinear dynamical system. [less ▲]

Detailed reference viewed: 31 (4 ULiège)
Peer Reviewed
See detailLow GH hypophyseal adenomas with acromegaly exhibit undetectable levels of messenger RNA of normal GH
Pagesy, P.; Rentier-Delrue, Françoise ULiege; Bresson, D. et al

in Annals of Endocrinology (1987), 48

Detailed reference viewed: 25 (0 ULiège)
Full Text
Peer Reviewed
See detailLow incidence of anti-osteoporosis treatment after hip fracture.
Rabenda, Véronique ULiege; Vanoverloop, Johan; Fabri, Valerie et al

in Journal of Bone & Joint Surgery. American Volume (2008), 90(10), 2142-8

BACKGROUND: Following hip fracture, pharmacologic treatment can reduce the rate of subsequent fragility fractures. The objective of the present study was to assess the proportion of patients who are ... [more ▼]

BACKGROUND: Following hip fracture, pharmacologic treatment can reduce the rate of subsequent fragility fractures. The objective of the present study was to assess the proportion of patients who are managed with bisphosphonates or selective estrogen-receptor modulators after hip fracture and to evaluate, among those managed with alendronate, the twelve-month compliance and persistence with treatment. METHODS: Data were gathered from health insurance companies and were collected by AIM (Agence Intermutualiste) for the Belgian National Social Security Institute (INAMI). We selected all postmenopausal women who had been hospitalized for a hip fracture between April 2001 and June 2004 and had not been previously managed with bisphosphonates. Patients who had received alendronate treatment after the hip fracture were categorized according to their formulation use during the follow-up study (daily, weekly, daily followed by weekly, or weekly followed by weekly). Compliance at twelve months was quantified with use of the medication possession ratio (i.e., the number of days of alendronate supplied during the first year of treatment, divided by 365). Persistence with prescribed treatment was calculated as the number of days from the initial prescription to a lapse of more than five weeks after completion of the previous prescription refill. The cumulative treatment persistence rate was determined with use of Kaplan-Meier survival curves. RESULTS: A total of 23,146 patients who had sustained a hip fracture were identified. Of these patients, 6% received treatment during the study period: 4.6% received alendronate, 0.7% received risedronate, and 0.7% received raloxifene. Bisphosphonate treatment was dispensed to 2.6% and 3.6% of the patients within six months and one year after the occurrence of the hip fracture, respectively. Among women who received alendronate daily (n = 124) or weekly (n = 182) and were followed for at least one year after the hip fracture, the twelve-month mean medication possession ratio was 67% (65.9% in the daily group and 67.7% in the weekly group). The analysis of persistence with treatment included a total of 726 patients (142 in the daily group, 261 in the weekly group, and 323 in the switch group). At twelve months, the rate of persistence was 41% and the median duration of persistence was 40.3 weeks. CONCLUSIONS: The vast majority of patients who experience a hip fracture do not take anti-osteoporotic therapy after the fracture. Furthermore, among patients who begin alendronate treatment after the fracture, the adherence to treatment decreases over time and remains suboptimal. [less ▲]

Detailed reference viewed: 80 (7 ULiège)
Full Text
Peer Reviewed
See detailLow incidence of osteoporosis treatment after hip fracture
Rabenda, Véronique ULiege; Mertens, Raf; Fabri, Valérie et al

in Osteoporosis International (2007, March), 18(Suppl.1), 72-73

Detailed reference viewed: 17 (2 ULiège)
See detailLow level measurement for superconductors
Vanderbemden, Philippe ULiege

Conference (2012, May 15)

Detailed reference viewed: 8 (2 ULiège)
Full Text
Peer Reviewed
See detailLow macrolide resistance in Streptococcus pyogenes in Southern Argentina.
Rubinstein, Gabriela; Amoroso, Ana Maria ULiege; Bavdaz, Barbara et al

in International journal of antimicrobial agents (2005), 25(5), 450-2

Detailed reference viewed: 13 (1 ULiège)
Full Text
Peer Reviewed
See detailLow molecular weight heparin and central neural blockade
BRICHANT, Jean-François ULiege

in BRICHANT, Jean-François (Ed.) Low molecular weight heparin and central neural blockade (1997)

Detailed reference viewed: 8 (1 ULiège)
Full Text
Peer Reviewed
See detailLow molecular weight poly (2-dimethylamino ethylmethacrylate) polymers with controlled positioned fluorescent labeling: Synthesis, characterization and in vitro interaction with human endothelial cells.
Flebus, Luca ULiege; Lombart, François ULiege; Sevrin, Chantal et al

in International journal of pharmaceutics (2015), 478(1), 278-287

Poly (2-dimethylamino ethylmethacrylate) (PDMAEMA) is an attractive non-degradable polymer studied as nonviral vector for gene delivery but it can be also adopted for delivery of other biopharmaceutical ... [more ▼]

Poly (2-dimethylamino ethylmethacrylate) (PDMAEMA) is an attractive non-degradable polymer studied as nonviral vector for gene delivery but it can be also adopted for delivery of other biopharmaceutical drugs. As a parenteral carrier, the PDMAEMA free form (FF) might interact with tissues and cells. Few data are available on its selective internalization and efflux from cells, while the majority of studies published have followed the distribution of DNA complexed with PDMAEMA. In order to address polycation safety, the first aim was to synthesize by atom transfer radical polymerisation (ATRP) fluorescent labeled PDMAEMA of low molecular weight (Mw) (below 15kDa), controlling the position and density of fluorescein. The second goal was to analyze the possible difference in uptake and subcellular distribution of this labeled FF polycation between human umbilical vein endothelial cells (HUVEC) and hCMEC/D3 cells. These two cell lines have been chosen in order to detect selectivity towards the blood-brain barrier (BBB). In both cases, polycation was detected along the plasma membrane followed by progressive migration to the peri-nuclear region, where it overlapped with lysosomal structures. The analysis by fluorescence-activated cell sorting (FACS) of the PDMAEMA uptake by hCMEC/D3 cells showed a significant (p<0.05) inhibition (40%) in presence of 2-dexoxy-d-glucose inhibitor, a result supporting an energy-dependence mechanism(s). Cytotoxicity study showed that low Mw PDMAEMA (10kDa) lead to a minor cytotoxicity compared to the higher ones. As main conclusion this study highlights the similitude in cell trafficking of FF PDMAEMA and data previously reported for PDMAEMA/DNA complexes. [less ▲]

Detailed reference viewed: 47 (9 ULiège)
Peer Reviewed
See detailLow noise vacuum-packaged MEMS closed-loop accelerometer using sixth-order multi-feedback loops and local resonator sigma-delta modulators
Chen, F; Yuan, W; Chang, H et al

in Proceedings of "IEEE MEMS Conf. : San Francisco- Janvier 2014" (2014, January)

Detailed reference viewed: 36 (1 ULiège)